BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 12946453)

  • 1. Protective activity of Lentinan in experimental tuberculosis.
    Markova N; Kussovski V; Drandarska I; Nikolaeva S; Georgieva N; Radoucheva T
    Int Immunopharmacol; 2003 Oct; 3(10-11):1557-62. PubMed ID: 12946453
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined immunomodulating effects of BCG and Lentinan after intranasal application in guinea pigs.
    Drandarska I; Kussovski V; Nikolaeva S; Markova N
    Int Immunopharmacol; 2005 Apr; 5(4):795-803. PubMed ID: 15710347
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intranasal application of lentinan enhances bactericidal activity of rat alveolar macrophages against Mycobacterium tuberculosis.
    Markova N; Michailova L; Kussovski V; Jourdanova M; Radoucheva T
    Pharmazie; 2005 Jan; 60(1):42-8. PubMed ID: 15700777
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of morphine during Mycobacterium tuberculosis H37Rv infection in mice.
    Singh RP; Jhamb SS; Singh PP
    Life Sci; 2008 Jan; 82(5-6):308-14. PubMed ID: 18191418
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of intraperitoneal and intranasal application of Lentinan on cellular response in rats.
    Markova N; Kussovski V; Radoucheva T; Dilova K; Georgieva N
    Int Immunopharmacol; 2002 Nov; 2(12):1641-5. PubMed ID: 12469938
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The shiitake mushroom-derived immuno-stimulant lentinan protects against murine malaria blood-stage infection by evoking adaptive immune-responses.
    Zhou LD; Zhang QH; Zhang Y; Liu J; Cao YM
    Int Immunopharmacol; 2009 Apr; 9(4):455-62. PubMed ID: 19189863
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Schistosoma mansoni infection reduces the protective efficacy of BCG vaccination against virulent Mycobacterium tuberculosis.
    Elias D; Akuffo H; Pawlowski A; Haile M; Schön T; Britton S
    Vaccine; 2005 Feb; 23(11):1326-34. PubMed ID: 15661380
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Novel vaccines against M. tuberculosis].
    Okada M
    Kekkaku; 2006 Dec; 81(12):745-51. PubMed ID: 17240920
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Specificity and efficacy of dendritic cell-based vaccination against tuberculosis with complex mycobacterial antigens in a mouse model.
    Rubakova E; Petrovskaya S; Pichugin A; Khlebnikov V; McMurray D; Kondratieva E; Baturina I; Kondratieva T; Apt A
    Tuberculosis (Edinb); 2007 Mar; 87(2):134-44. PubMed ID: 17011827
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activity of diclofenac used alone and in combination with streptomycin against Mycobacterium tuberculosis in mice.
    Dutta NK; Mazumdar K; Dastidar SG; Park JH
    Int J Antimicrob Agents; 2007 Oct; 30(4):336-40. PubMed ID: 17644321
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Release of superoxide anion from activated mouse peritoneal macrophages during Mycobacterium tuberculosis infection.
    Khanna M; Srivastava LM
    Indian J Exp Biol; 1996 May; 34(5):468-71. PubMed ID: 9063079
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Restoration of impaired free radical generation and proinflammatory cytokines by MCP-1 in mycobacterial pathogenesis.
    Majumder N; Bhattacharjee S; Bhattacharyya Majumdar S; Dey R; Guha P; Pal NK; Majumdar S
    Scand J Immunol; 2008 Apr; 67(4):329-39. PubMed ID: 18282229
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protective efficacy of piperine against Mycobacterium tuberculosis.
    Sharma S; Kalia NP; Suden P; Chauhan PS; Kumar M; Ram AB; Khajuria A; Bani S; Khan IA
    Tuberculosis (Edinb); 2014 Jul; 94(4):389-96. PubMed ID: 24880706
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The immunogenicity and protective efficacy of Mtb8.4/hIL-12 chimeric gene vaccine.
    Li H; Li R; Zhong S; Ren H; Zou Y; Chen X; Shi X; Wang M; Long H; Luo Y
    Vaccine; 2006 Feb; 24(9):1315-23. PubMed ID: 16219397
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Frontier of mycobacterium research--host vs. mycobacterium].
    Okada M; Shirakawa T
    Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mucosal immunization with recombinant heparin-binding haemagglutinin adhesin suppresses extrapulmonary dissemination of Mycobacterium bovis bacillus Calmette-Guérin (BCG) in infected mice.
    Kohama H; Umemura M; Okamoto Y; Yahagi A; Goga H; Harakuni T; Matsuzaki G; Arakawa T
    Vaccine; 2008 Feb; 26(7):924-32. PubMed ID: 18192091
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Macrophages play a dual role during pulmonary tuberculosis in mice.
    Leemans JC; Thepen T; Weijer S; Florquin S; van Rooijen N; van de Winkel JG; van der Poll T
    J Infect Dis; 2005 Jan; 191(1):65-74. PubMed ID: 15593005
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monoclonal antibody-dependent murine macrophage-mediated cytotoxicity against human tumors is stimulated by lentinan.
    Herlyn D; Kaneko Y; Powe J; Aoki T; Koprowski H
    Jpn J Cancer Res; 1985 Jan; 76(1):37-42. PubMed ID: 3918909
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alternative activation deprives macrophages of a coordinated defense program to Mycobacterium tuberculosis.
    Kahnert A; Seiler P; Stein M; Bandermann S; Hahnke K; Mollenkopf H; Kaufmann SH
    Eur J Immunol; 2006 Mar; 36(3):631-47. PubMed ID: 16479545
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Direct comparison of low-dose and Cornell-like models of chronic and reactivation tuberculosis in genetically susceptible I/St and resistant B6 mice.
    Radaeva TV; Nikonenko BV; Mischenko VV; Averbakh MM; Apt AS
    Tuberculosis (Edinb); 2005; 85(1-2):65-72. PubMed ID: 15687029
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.